Evidence map›Paper›PMID 19483649›Full record

ArticleJournal of immunotherapy (Hagerstown, Md. : 1997)

Radiotherapy combined with intratumoral dendritic cell vaccination enhances the therapeutic efficacy of adoptive T-cell transfer.

Seagal Teitz-Tennenbaum, Qiao Li, Mary A Davis, Kari Wilder-Romans, Janet Hoff, Mu Li, Alfred E Chang

Abstract read
In one paragraph

Article in Journal of immunotherapy (Hagerstown, Md. : 1997). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect.International journal of molecular sciences · 2021
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Seagal Teitz-TennenbaumDepartment of Surgery, University of Michigan Medical Center, Ann Arbor, Michigan 48109-0932, USA.
Qiao Li
Mary A Davis
Kari Wilder-Romans
Janet Hoff
Mu Li
Alfred E Chang
Radiation Oncology Associates · USUniversity of Michigan–Ann Arbor · US

Funding

SLC and dendritic cells in antitumor immunity &therapyP01CA059327 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHANG, ALFRED E · 1992 to 2005
$8.2M
T CELL ACTIVATION FOR CANCER IMMUNOTHERAPYR01CA082529 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHANG, ALFRED E · 1999 to 2008
$2.8M
NCI NIH HHS CA59327NCI NIH HHS P01 CA059327NCI NIH HHS R01 CA082529
6 · The paper itself

Abstract

Treatment of C57BL/6 mice with cyclophosphamide (100 mg/kg) and fludarabine (200 mg/kg) induced nonmyeloablative lymphodepletion without inhibiting D5 melanoma tumor growth. Using this model, we found that induction of lymphopenia before adoptive transfer of ex vivo anti-CD3/CD28 activated and interleukin-2 expanded D5-G6 tumor draining lymph node cells enhanced the antitumor efficacy of the infused cells in both pulmonary metastases and subcutaneous D5 bearing mice. However, induction of lymphopenia did not promote intratumoral or extratumoral proliferation or accumulation of the infused cells. We have previously shown that radiotherapy enhances the therapeutic efficacy of intratumoral unpulsed dendritic cell vaccination in subcutaneous murine tumor models by augmenting the induction of antitumor cellular immune responses. Here, we confirmed this finding in a murine metastatic melanoma liver tumor model. Furthermore, local tumor irradiation combined with intratumoral dendritic cell administration significantly enhanced the therapeutic efficacy of tumor-reactive T cell adoptive transfer in this lymphodepleted liver tumor model. This was evident by reduced liver tumor size, decreased incidence of spontaneous intra-abdominal metastasis, and prolonged survival, resulting in 46% of mice cured. This enhanced antitumor activity was associated with a selective increase in proliferation, accumulation, and function of CD4+ rather than CD8+ infused cells. This multimodality regimen may have translational applications for the treatment of human cancers.

Indexed as

Immunotherapy, AdoptiveAnimalsAntineoplastic AgentsCancer VaccinesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCombined Modality TherapyCyclophosphamideDendritic CellsFemaleImmunosuppressive AgentsLiver NeoplasmsLung NeoplasmsLymph NodesLymphopeniaMelanoma, ExperimentalAntineoplastic AgentsCancer VaccinesCyclophosphamidefludarabineImmunosuppressive AgentsVidarabine

Identifiers

PMID19483649
PMCPMC2743975
OpenAlexW2058725042

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.